Advisors Preferred’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Advisors Preferred's JAZZ Position: Q2 2026 in Review
Advisors Preferred opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 20,861 shares worth $5.08M. The stake represents 0.79% of the portfolio and ranks #40 among its holdings. This is a return to the name: Advisors Preferred previously reported a position in JAZZ as recently as Q3 2024.
Advisors Preferred first reported a position in JAZZ in Q3 2024 and has held it in 2 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Advisors Preferred held 20,861 shares of Jazz Pharmaceuticals worth $5.08M as of Q2 2026.
- Jazz Pharmaceuticals was a new Advisors Preferred position in Q2 2026.
- Jazz Pharmaceuticals made up 0.79% of Advisors Preferred's portfolio in Q2 2026, its #40 holding.
- Advisors Preferred first reported a position in Jazz Pharmaceuticals in Q3 2024 and has held it in 2 quarters since.
- 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Advisors Preferred's 13F filing for Q2 2026, filed 11 Aug 2026.